Qkine
PrivateLast Round
VC Round
Mar 21, 2025
Total Funding Raised
$3.15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Qkine is a biotechnology company that manufactures high-purity, animal-free growth factors, cytokines, and other complex proteins for life science applications, including stem cell and organoid culture.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qkine Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Qkine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 21, 2025 | ||||
| Debt | Dec 19, 2022 | ||||
| VC Round | Dec 15, 2022 | ||||
| Series A | Jun 8, 2020 | ||||
| Seed | Jun 3, 2019 | ||||
Seed | Apr 23, 2018 |
Qkine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Debt |
| o2h ventures | VC Round |
| Cambridge Enterprise | Seed, Series A |
| Downing Ventures | VC Round |
| Parkwalk Advisors | VC Round, Series A |
| Oxford Innovation Finance | VC Round |
| Martlet Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2026
Launched QkPlate (C), pre-prepared dried vitronectin-coated plates.
- Mar 23, 2026
Developing QkPlate (C) human vitronectin coated plates.
Qkine Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Qkine's valuation, stock price, and market status.